Skip to content
DataLookout
Menu

DAIRYNCT06694155

Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 3 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 21 words Show 5 more changesShow less
    • Primary completion pushed from Nov 1, 2026 to Feb 28, 2027
    • Study completion pushed from Mar 1, 2027 to Dec 31, 2027
    • Secondary endpoints: details revised at 1 of 2 entries
    • Site contact updated
    • Study description expanded, about 3 words
  2. Notable Eligibility criteria expanded, about 11 words
    • Study completion date: Nov 1, 2026 to Mar 1, 2027
    v6
  3. Minor Site contact updatedv4
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Dec 1, 2024 to Jan 15, 2025
    • Site details revised
    v3
  5. Minor Interventions: Whey Protein Isolate Crossover (Dietary Supplement) to Placebo (Dietary Supplement), Whey Protein Isolate Crossover (Dietary Supplement)
    • Secondary endpoints: details revised at 1 of 2 entries
    v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Whole body protein turnover
Timeframe: 7 days
Oral Glucose Tolerance Test
Timeframe: 7 days
Blood glucose
Timeframe: 7 days

Secondary (2)

Composite Appetite Scale
Dietary Intake Log

Arms and interventions

Whey Protein SupplementationExperimental

Crossover study

Placebo SupplementationPlacebo comparator

Crossover study

Dietary supplements: Whey Protein Isolate Crossover, Placebo

Sites

1 site in 1 country

  • University of Arkansas for Medical SciencesLittle Rock, Arkansas, United States